Search

Your search keyword '"Conley, David B"' showing total 590 results

Search Constraints

Start Over You searched for: Author "Conley, David B" Remove constraint Author: "Conley, David B"
590 results on '"Conley, David B"'

Search Results

3. Single cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissue

4. IL-13 and IL-13–induced periostin levels are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis

5. ACR Appropriateness Criteria® Cranial Neuropathy: 2022 Update

10. Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps

11. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps

13. ACR Appropriateness Criteria® Neck Mass-Adenopathy

16. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase

18. Contributors

19. Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis

20. Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps

21. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease

23. Retinoic acid promotes fibrinolysis and may regulate polyp formation

25. IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells

27. Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps

28. Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps

29. Persistent discharge or edema after endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with a type 1 or 3 endotype

30. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease

31. Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis

32. Use of intraoperative frontal sinus mometasone‐eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps

33. Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps

34. CRS‐PRO and SNOT‐22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis

35. Anti‐phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps

36. Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis

47. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease

49. International Consensus Statement on Rhinology and Allergy: Rhinosinusitis

50. Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis

Catalog

Books, media, physical & digital resources